J&J Rolls Out Industry Model Clinical Trial Data-Sharing Plan

Drug Industry Daily
Johnson & Johnson Thursday unveiled a clinical trial data-sharing plan that it hopes will become a model for all industry transparency initiatives: instead of providing direct access to trial data, a third party will serve as gatekeeper and approve access requests for data.

To View This Article:


Subscribe To Drug Industry Daily